News

April 13-16th – Join us for this year’s ACMG Annual Clinical Genetics Meeting in a fully virtual format and watch our Product Theaters presentation.

CONFERENCE

Scaling the Analysis of Rare Disease Cases in a Children’s Hospital Clinical Lab

September 23, 2022, Virtual

For Meetings, Contact:
info@fabricgenomics.com

CONFERENCE

Precision Medicine World Conference 2022

June 28, 2022 - June 30, 2022, Silicon Valley, California

For Meetings, Contact:
info@fabricgenomics.com

CONFERENCE

European Human Genetics Conference 2022

June 11, 2022 - June 13, 2022, Vienna, Austria

For Meetings, Contact:
info@fabricgenomics.com

CONFERENCE

WEBINAR: A Universal AI-based Whole Genome Sequencing Solution for Genetic Screening and Diagnosis

For Meetings, Contact:
info@fabricgenomics.com

CONFERENCE

Artificial Intelligence in Healthcare & Diagnostics Conference

For Meetings, Contact:
info@fabricgenomics.com

CONFERENCE

ACMG 2022

March 24 2022, Virtual

April 13-16th – Join us for this year’s ACMG Annual Clinical Genetics Meeting in a fully virtual format and watch our Product Theaters presentation.

CONFERENCE

ESHG 2021

For Meetings, Contact:
info@fabricgenomics.com

CONFERENCE

AMP Europe 2021

For Meetings, Contact:
info@fabricgenomics.com

CONFERENCE

PMLS Virtual Series 2021

For Meetings, Contact:
info@fabricgenomics.com

News & Press

NEWS | March 13, 2024

Fabric Genomics Partners with Intermountain Children’s Health to Enhance Precision Diagnosis of Infants and Children Using Whole Genome Sequencing from Broad Clinical Labs

Fabric Genomics, the leader in artificial intelligence (AI)-powered next generation sequencing interpretation, is announcing a new partnership with Intermountain Children’s Health to analyze the whole genomes of children sequenced by the Broad Clinical Labs to help speed diagnosis of kids who may have genetic diseases.

NEWS | December 7, 2023

PlumCare and Fabric Genomics Announce a Strategic Partnership to Integrate the Fabric AI Platform with PlumCare’s FirstSteps™ Newborn Genome Screening Program in Greece

Fabric AI technology for interpretation of the human genome, powered by the Fabric GEM AI algorithm, will be adapted into the FirstSteps clinical support tool, empowering clinicians to provide timely medical intervention for patients with rare genetic diseases in Greece.

NEWS | November 1, 2023

Fabric Genomics and DNAnexus Team Up to Improve Scale and Speed of Data Analysis for Genomic Medicine

The newly formed partnership will enable clinical genomics laboratories to move from sample to evidence-backed analysis to actionable clinical reports using a push-button solution.

NEWS | April 20, 2023

Metrodora Institute Launches to Advance the Treatment of Complex Neuroimmune Diseases and Accelerate the Path to Cures

Fabric’s AI platform will help identify and prioritize new genome variants associated with neuroimmune axis disorders and accelerate clinical diagnostics for these conditions.

NEWS | April 11, 2023

Broad Institute launches new $1K Sample-to-Report Clinical Whole-Genome Sequencing Service in Partnership with Fabric Genomics

Priced at $1,000 per sample, the new test promises to be competitive with other offerings in the market
while offering better cost transparency.

NEWS | September 14, 2022

Sean Hofherr, PhD, FACMG, named Chief Operating Officer and Clinical Director

Hofher, Former Chief Scientific Officer of GeneDx, is the latest addition to Fabric Genomics’ expanding leadership team

NEWS | July 27, 2022

Study Supports Potential of Genome-to-Treatment (GTRx™) to Guide Physicians in the Management of 500 Treatable Genetic Diseases

A new study in Nature Communications describes and examines the performance of Rady Children’s Institute for Genomic Medicine’s Genome-to-Treatment (GTRx™), a clinical decision support tool on which Fabric is a research collaborator.

NEWS | July 26, 2022

Fabric’s PHEVOR WGS Algorithm Used to Find New Gene for Renal Disease

Fabric’s PHEVOR WGS algorithm used in recent University of Utah School of Medicine study featured in npj Genomic Medicine: “A dominant negative ADIPOQ mutation in a diabetic family with renal disease, hypoadiponectinemia, and hyperceramidemia”

NEWS | June 30, 2022

RCIGM Launches Program to Advance Newborn Screening for Treatable Genetic Diseases

BeginNGS™ to accelerate newborn screening by rapid whole genome sequencing to help diagnose and treat genetic diseases with available therapies, Fabric honored to have been a collaborator

NEWS | October 31, 2023

Oxford Nanopore Technologies and Fabric Genomics collaborate to launch an integrated whole-genome sequencing solution to advance the future of paediatric patient care

The partners will offer an integrated sample-to-report rapid nanopore sequencing analysis platform for neonatal/paediatric intensive care units to support clinicians in acute settings.

NEWS | March 8, 2022

The Broad Institute Selects Fabric Genomics in Implementation of Clinical Whole Genome Sequencing Offering

Fabric Genomics will provide the AI-based platform used to support the interpretation of clinical whole genomes and custom assays.

NEWS | February 28, 2022

Element Biosciences Partners With Fabric Genomics to Demonstrate the AVITI™ System’s NGS Data Quality and to Explore Clinical Applications

Element Biosciences and Fabric Genomics to explore commercialization of end-to-end clinical application solutions based on Element’s AVITI system and the Fabric Enterprise clinical interpretation platform.

NEWS | January 17, 2022

Fabric Genomics Algorithm Validated for Rare Disease Diagnosis in Two New Studies

GenomeWeb looks at two recent studies that lend support to Fabric Genomics' artificial intelligence-based algorithm in helping to diagnose genetic diseases, providing further validation of the end-to-end software tool intended to help labs launch genomic testing programs.

NEWS | November 10, 2021

Fabric Genomics Technology Supports Global Scientific Study of Whole Genome Sequencing in Rare Disease Diagnosis

New England Journal of Medicine publication showcases technology-driven variant detection platforms in accurately identifying causative genetic mutations

NEWS | October 14, 2021

Benchmark Genome Study Demonstrates Accuracy of Artificial Intelligence in Rapidly Diagnosing Rare Diseases in Critically Ill Patients

Pivotal study led by Fabric Genomics and Rady Children's Institute for Genomic Medicine demonstrates that artificial intelligence can enable the accurate and rapid clinical diagnosis of rare diseases in critically ill newborns based on whole-genome or whole-exome analyses

NEWS | April 9, 2021

Study Shows Fabric Genomics’ Algorithm Can Speed Up, Increase Genetic Disease Diagnoses Through Rapid Identification of Structural Variants

In a study involving 56 rare genetic disease cases with causal SVs, Fabric GEM – Fabric Genomics’ AI gene-ranking algorithm – provided a unified approach to analyzing SVs and SNVs in a single step, correctly identifying 96 percent of these SVs. Moreover, GEM identified the causal SV in the top five list of all candidates (SVs and SNVs) 93 percent of the time, requiring review of fewer than five candidates per case.

NEWS | November 20, 2019

Watch Now: Applying Artificial Intelligence to Accelerate Variant Classification and Clinical Reporting of NGS Gene Panels

Watch the talk by Francisco De La Vega to see how panel testing with Fabric ACE enables clinical labs to perform rapid genomic interpretation to uncover critical insights that reduce costs and save lives.

NEWS | November 27, 2017

Clinical OMICS Magazine Nov/Dec 2017 Features Dr. Stephen Kingsmore, Rady Children’s Hospital & Fabric Genomics

Ring in the New: Rady Children’s Hospital Introduces NovaSeq for a Newborn Diagnosis. “The sequence data are fed into a rapid analysis pipeline using Edico Genome’s DRAGEN processing platform and Fabric Genomics’ Opal clinical variant platform for interpretation.”

NEWS | November 27, 2017

Clinical OMICS Magazine Nov/Dec 2017 Covers Fabric Genomics’ Partnership with Genome Medical

Pushing a New Standard: Genome Medical, Fabric Genomics Partnership Helps Push Genomic Medicine into the Mainstream

NEWS | June 8, 2017

Clinical OMICS Magazine May/June 2017 Highlights Fabric Genomics’ Oncology Clinical Platform

Fabric Genomics and TOMA Biosciences announced a partnership in April to develop an end-to-end genomic testing and clinical interpretation product for somatic cancers. The new system integrates TOMA’s oligo selective sequencing (OS-Seq) technology, which was developed at Stanford University, and combines it with Fabric Genomics’ bioinformatics platform. “What TOMA does is a very specialized assay …